Russian government to provide additional support to drugmakers

The Russian government has designed a new package of measures aimed at providing support to domestic drugmakers as well as global majors, operating their plants within the country.

The new measures involve the increase of the maximum volume of subsidies to producers from 200 to 400 million roubles (~$3-$6 million), as well as abolishing the existing practice of licensing of the production of some types of drugs, the list of which will be announced later this year, reports The Pharma Letter’s local correspondent.

According to plans of the Russian Ministry of Health, the number of activities that will be subject of subsidization from the state will be significantly increased. This will involve the provision of grants for the payments to participants of clinical trials, compensation of costs associated with the preparation of documents as well as wages for highly skilled professionals.